rs773004328
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014838.3(ZBED4):c.46G>A(p.Val16Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,453,120 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014838.3 missense
Scores
Clinical Significance
Conservation
Publications
- ALG12-congenital disorder of glycosylationInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZBED4 | ENST00000216268.6 | c.46G>A | p.Val16Ile | missense_variant | Exon 2 of 2 | 1 | NM_014838.3 | ENSP00000216268.4 | ||
ZBED4 | ENST00000850559.1 | c.46G>A | p.Val16Ile | missense_variant | Exon 2 of 2 | ENSP00000520851.1 | ||||
ZBED4 | ENST00000850560.1 | n.260+230G>A | intron_variant | Intron 2 of 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000401 AC: 10AN: 249074 AF XY: 0.0000297 show subpopulations
GnomAD4 exome AF: 0.0000186 AC: 27AN: 1453120Hom.: 0 Cov.: 29 AF XY: 0.0000139 AC XY: 10AN XY: 721532 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.46G>A (p.V16I) alteration is located in exon 2 (coding exon 1) of the ZBED4 gene. This alteration results from a G to A substitution at nucleotide position 46, causing the valine (V) at amino acid position 16 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at